EUDA Health Holdings (EUDA) Return on Sales (2022 - 2024)
Historic Return on Sales for Health Holdings (EUDA) over the last 3 years, with Q4 2024 value amounting to 45.81%.
- Health Holdings' Return on Sales fell 418300.0% to 45.81% in Q4 2024 from the same period last year, while for Dec 2024 it was 45.81%, marking a year-over-year decrease of 418300.0%. This contributed to the annual value of 0.56% for FY2024, which is 9900.0% up from last year.
- Latest data reveals that Health Holdings reported Return on Sales of 45.81% as of Q4 2024, which was down 418300.0% from 3.99% recorded in Q2 2024.
- Health Holdings' Return on Sales' 5-year high stood at 0.08% during Q1 2022, with a 5-year trough of 45.81% in Q2 2023.
- In the last 3 years, Health Holdings' Return on Sales had a median value of 2.7% in 2023 and averaged 12.75%.
- As far as peak fluctuations go, Health Holdings' Return on Sales crashed by -450500bps in 2023, and later soared by 418300bps in 2024.
- Health Holdings' Return on Sales (Quarter) stood at 0.32% in 2022, then tumbled by -1142bps to 3.99% in 2023, then crashed by -1049bps to 45.81% in 2024.
- Its Return on Sales was 45.81% in Q4 2024, compared to 3.99% in Q2 2024 and 3.99% in Q4 2023.